all hospitalized patients receiving a consultation report by a specialist for infectious diseases
Conditions
Interventions
Group 1: Aquisition and evaluation of data on co-medication, previous diagnoses, patient complexity, previous antimicrobial therapies, recommendations of the consultant, adhrence to the recommendation
Sponsors
Abteilung Infektiologie, Medizinische Klinik II, Universitätsklinik Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients age = 18 Jahre, who are hospitalized and receive an infectious disease consultant report written informed consent of the participant or of a legally acceptable represantative
Exclusion criteria
Exclusion criteria: lack of consent to participate in the study Age <18 years Death within 24 hours after involvement of the ID consultant service
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment results as a composite endpoint consisting of intrahospital mortality, mortality until day 90, treatment failure (clinical / microbiological) and readmission rate within 90 days for bloodstream infections caused by S. aureus, Candida spp., MRGN pathogens and VRE | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment results as a composite endpoint consisting of intrahospital mortality, mortality until day 90, treatment failure (clinical / microbiological) and readmission rate within 90 days for defined indicator diseases (bloodstream infections, osteoarticular infections, intravascular infections and neurological / neurosurgical infections, each with or without foreign body devices); Correlation of adherence to the ID consultant's recommendations (measured as AID score) with treatment results and patient's outcome; Adherence to ID consultant's recommendations (measured as AID score) depending on the requesting disciplines; Influence of the time of ID consultant service involvement on adherence (AID score) and treatment results; Hospital length of stay, effective case mix, PCCL (Patient Clinical Complexity Level), length of stay DRG-related, deviations from the mean length of stay, length of stay in intensive care unit, ventilation hours, type of discharge, number of secondary diagnoses, number of contacts with other specialist departments, number of readmissions; Antibiotic consumption / costs (DDD, averaged economic consumption data); Anamnestic allergies towards beta-lactams, excluded allergies towards beta-lactam by the ID specialist; Fulfillment of identified quality indicators of ID consult reports and their effects on treatment results; Recording of the disease entities, which are also discussed in interdisciplinary boards | — |
Countries
Germany
Contacts
Public ContactHeike Spitznagel
Abteilung Infektiologie, Medizinische Klinik II, Universitätsklinik Freiburg
Outcome results
None listed